Nymox Pharmaceutical
NYMX
#10793
Rank
NZ$32.52 M
Marketcap
Country
NZ$0.36
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): NZ-$0.09947

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$0.11. In 2022 the company made an earnings per share (EPS) of NZ-$0.14 an increase over its 2021 EPS that were of NZ-$0.27.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$0.09947-30.22%
2022NZ-$0.14-46.67%
2021NZ-$0.27-11.76%
2020NZ-$0.30-15%
2019NZ-$0.365.26%
2018NZ-$0.34-26.92%
2017NZ-$0.46-7.14%
2016NZ-$0.50-40.43%
2015NZ-$0.84291.67%
2014NZ-$0.21-7.69%
2013NZ-$0.23-43.48%
2012NZ-$0.41-25.81%
2011NZ-$0.5555%
2010NZ-$0.3625%
2009NZ-$0.290.08%
2008NZ-$0.28-11.12%
2007NZ-$0.32-0.16%
2006NZ-$0.3228.59%
2005NZ-$0.25-12.49%
2004NZ-$0.29-16.05%
2003NZ-$0.3419.07%
2002NZ-$0.2914.45%
2001NZ-$0.25-22.16%
2000NZ-$0.325.64%
1999NZ-$0.30-34.59%
1998NZ-$0.46-3.6%
1997NZ-$0.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.56-14,656.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.35-1,366.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$5.56-5,296.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.25-49,906.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$17.00-16,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA